A Phase 1 Study Evaluating Eliglustat’s Effects on Pharmacokinetics, Safety & Tolerability of Digoxin in Healthy Adults
Condition(s):Healthy VolunteerLast Updated:March 23, 2015Completed
Hide Studies Not Open or Pending
Condition(s):Healthy VolunteerLast Updated:March 23, 2015Completed
Condition(s):Type 2 Diabetes MellitusLast Updated:January 5, 2011Completed
Condition(s):Inflammatory ResponseLast Updated:February 16, 2024Completed
Condition(s):Nonalcoholic SteatohepatitisLast Updated:February 22, 2023Withdrawn
Condition(s):Heart FailureLast Updated:June 1, 2016Completed
Condition(s):Congenital Heart DiseaseLast Updated:October 12, 2022Completed
Condition(s):Heart Failure; Atrial FibrillationLast Updated:February 1, 2017Completed
Condition(s):Alzheimer Disease; Huntington DiseaseLast Updated:June 12, 2009Completed
Condition(s):HealthyLast Updated:January 24, 2017Completed
Condition(s):Healthy Volunteers; PharmacokineticsLast Updated:December 2, 2010Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.